AbCellera Biologics (ABCL) executive compensation, 2026 proxy

Carl L.G. Hansen, Ph.D., Chief Executive Officer, was paid $6.3M in 2025, down 24% from $8.2M the year before. The CEO-to-median-employee pay ratio was 52:1, on median employee pay of $122,119.

Filed
April 29, 2026
Annual meeting
June 11, 2026
Pay year
2025
Named executives
4
CEO total pay
$6.3M-24% vs prior year
CEO to median employee
52:1median $122,119
Prior say-on-pay support
88%of votes cast
CEO Target Bonus
65%Percentage of annual base salary
CFO Target Bonus
45%Percentage of annual base salary
Available Liquidity
$700MClosed year 2025
Clinical Facility
130,000 sq ftVancouver facility construction completed

How Ph.D. was paid

$6.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary9%Bonus6%Option awards85%All other compensation0%

Named executive officers

ExecutiveTotal
Carl L.G. Hansen, Ph.D.Chief Executive Officer$6,293,085
Andrew BoothChief Financial Officer$3,382,244
Véronique Lecault, Ph.D.Chief Technology Officer$2,315,758
Tryn StimartChief Legal Officer, Chief Compliance Officer, Corporate Secretary, and Privacy Officer$2,343,388

What changed and why

  • $6.3MCarl L.G. Hansen earned $6,293,085 in total compensation for fiscal 2025, reflecting a decrease from the prior year.
  • AbCellera advanced its first internal drug candidates into clinical development during 2025.
  • 88%The company received approximately 88% approval for its Say-on-Pay advisory vote at the 2025 annual meeting.
  • Annual cash incentive bonuses were awarded based on corporate and individual performance achievements for 2025.
  • Alpine Rewards served as the independent compensation consultant to the Compensation Committee throughout 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.